[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - Journal of traditional and …, 2021 - Elsevier
Abstract Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …

Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences

RR Narkhede, AV Pise, RS Cheke… - Natural products and …, 2020 - Springer
Abstract SARS-CoV-2 (2019-nCoV) emerged in 2019 and proliferated rapidly across the
globe. Scientists are attempting to investigate antivirals specific to COVID-19 treatment. The …

In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2

SS Mousavi, A Karami, TM Haghighi, SG Tumilaar… - Molecules, 2021 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which initially appeared in Wuhan, China, in …

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)

VA Falade, TI Adelusi, IO Adedotun… - In Silico …, 2021 - Springer
It is no longer news that a novel strain of coronavirus named SARS-CoV-2 is ravaging the
health sector worldwide, several attempts have been made to curtail this pandemic via …

Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target

Umesh, D Kundu, C Selvaraj, SK Singh… - Journal of …, 2021 - Taylor & Francis
Abstract The 2019-novel coronavirus (nCoV) has caused a global health crisis by causing
coronavirus disease-19 (COVID-19) pandemic in the human population. The unavailability …

In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2

M Rudrapal, AR Issahaku, C Agoni… - Journal of …, 2022 - Taylor & Francis
Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19,
the development of potent antiviral drug candidates/therapeutic molecules against COVID …

In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2

R Abdizadeh, F Hadizadeh, T Abdizadeh - Molecular Diversity, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by
SARS-CoV-2 that generated serious damages for both the human population and the global …

Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants–Emblica officinalis (Amla), Phyllanthus niruri Linn …

S Murugesan, S Kottekad, I Crasta… - Computers in biology …, 2021 - Elsevier
Abstract Coronavirus Disease-2019 (COVID-19), a viral disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) was declared a global pandemic by …

Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (Mpro): An integrated computational approach

SB Kumar, S Krishna, S Pradeep, DE Mathews… - Computers in biology …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a viral respiratory disease that has been
spreading across the globe. The World Health Organization (WHO) declared it as a public …

In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman, TA Hussien… - Computers in Biology …, 2020 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) is an infectious illness caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), originally identified in Wuhan …